Prior authorization

ADHD stimulants denied: Adderall, Vyvanse and Concerta

Stimulant denials mix prior authorization criteria, age rules and quantity limits, and sometimes a shortage is mistaken for a denial. Here is how to tell them apart and what an appeal has to show.

Adderall XRVyvanseConcertaRitalinFocalinQelbreeStratteralisdexamfetaminemethylphenidatemixed amphetamine salts

ADHD medication denials are unusually easy to misread, because three different things arrive at the pharmacy counter looking alike: a plan denial with appeal rights, a quantity or refill-timing rule, and a supply shortage that has nothing to do with your insurance. Sorting out which one you have is the first and most useful step.

Why was my ADHD medication denied?

Prior authorization criteria were not met. Policies typically ask for the diagnosis and its basis, sometimes the evaluating clinician, sometimes evidence of an ongoing treatment plan or monitoring. A prescription sent without those notes is denied on the paperwork.

Age and labeled indication. Products in this class carry different approved age ranges, and a request that falls outside the one the policy uses is denied on that basis even where the prescription is appropriate.

Quantity limits and early-fill rules. Controlled-substance rules restrict quantity and how soon a fill may be repeated. A rejection at the counter can be that rule rather than a coverage decision.

Step therapy. Some plans require a different agent, occasionally a non-stimulant, before the prescribed one is covered. That is answered as a step therapy override.

Reauthorization. Continuing coverage often has its own criteria, commonly a recent visit and documented benefit, and lapses at renewal are a frequent cause of a sudden denial.

What does the denial letter actually mean?

If you received a written notice from the plan, it must state the reason and tell you how and by when to appeal. "Prior authorization required" or "criteria not met" means the drug is covered and the submission fell short of a written rule, which is the most recoverable kind of denial. "Not a covered benefit" means the contract excludes it. "Quantity limit exceeded" means coverage exists and the amount requested does not fit the limit.

If you received nothing in writing, ask the plan for the denial notice and for the criteria it applied. A rejection you cannot see the reasons for cannot be answered, and you are entitled to ask.

What can I do in the next 48 hours?

Follow the general sequence in the first 48 hours after a denial, and add three steps for this class.

Confirm with the pharmacy whether the rejection came from the plan or from stock, because only one of those has an appeal. Ask the plan in writing for its coverage policy for the drug, including the reauthorization criteria if this is a renewal. Ask the prescriber's office for the diagnostic record, the treatment history with dates and doses, and the most recent visit note, since renewals usually turn on it.

The free denial check will tell you which appeal path a notice points to, in about a minute and with no account.

How does a physician-written appeal help for stimulant denials?

Because these criteria are procedural as well as clinical, the letter has to answer both halves. A licensed physician reviews the records, tells you candidly whether the case has merit, and where it does writes a letter that names the criterion the plan applied, evidences the diagnosis and how it was established, sets out prior treatment with dates, doses and outcomes, addresses the labeled indication and any age or quantity rule at issue, and cites the guidelines and labeling supporting the prescribed regimen.

Cove Health cannot guarantee results, but you should not have to navigate a controlled-substance coverage rule alone.

Cove Health provides advocacy services. Information on this site is general information, not legal or medical advice. Cove Health is not a law firm and does not provide legal representation, and submission of records does not guarantee a particular outcome.

Frequently asked questions

Prior authorization denials for this category, answered.

Why does an ADHD medication need prior authorization at all? +
Stimulants are controlled substances, and plans apply utilization management to them more heavily than to most drug classes. Policies commonly ask for the diagnosis and how it was established, the prescriber type, the age of the patient against the labeled indication, and sometimes documentation of prior therapy or of a treatment plan.
My pharmacy says the drug is unavailable. Is that a denial? +
No, and the distinction matters. A supply shortage is a stocking problem and produces no denial notice and no appeal rights. A coverage denial comes from the plan, names a reason and states a deadline. If you have no notice, ask the pharmacy whether the rejection came from the plan or from stock.
The plan approved this last year and denied the renewal. Why? +
Reauthorization criteria are often different from initial criteria. Plans commonly ask for evidence of continued benefit, a recent visit, or updated monitoring, and a renewal submitted without those is denied even when nothing about the treatment changed.
Can a plan require me to try a non-stimulant first? +
Some policies apply step therapy in this class. Where they do, the exception grounds are the usual ones: the required drug was already tried, is contraindicated, caused an intolerable reaction, or is expected to be ineffective for documented clinical reasons.
Does an adult diagnosis get treated differently? +
Coverage policies sometimes ask for more documentation where a diagnosis was made in adulthood, such as how the diagnostic criteria were established and by whom. That is a documentation requirement rather than a bar, and it is answered with the record of the evaluation.

Still have a question?